VYGR R&D Expense Growth
Voyager Therapeutics Inc · R&D Expense Growth
VYGR R&D Expense Growth
Latest reported5.74%period ending
VYGR FY R&D Growth (YoY) (0.00% → 5.74%)
Latest values, visible window
High-resolution chart · PNG
VYGR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.7361% | |
| 38.1851% | |
| 51.6885% | |
| -17.6495% | |
| -32.1518% | |
| -9.1719% | |
| 84.4773% | |
| 4.2483% | |
| 47.3644% | |
| 52.6392% | |
| 211.0699% | |
| 92.0984% | |
| 0% |